Filing Details
- Accession Number:
- 0001415889-22-003267
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-03-22 17:37:55
- Reporting Period:
- 2022-03-18
- Accepted Time:
- 2022-03-22 17:37:55
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1023024 | Ani Pharmaceuticals Inc | ANIP | Pharmaceutical Preparations (2834) | 582301143 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1871002 | Chad Gassert | C/O Ani Pharmaceuticals, Inc. 210 Main Street West Baudette MN 56623 | Svp - Corp. Dev. & Strategy | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2022-03-18 | 5,000 | $27.15 | 388,226 | No | 4 | P | Indirect | Held by Chali Properties LLC |
| Common Stock | Acquisiton | 2022-03-21 | 5,000 | $27.87 | 393,226 | No | 4 | P | Indirect | Held by Chali Properties LLC |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Indirect | Held by Chali Properties LLC |
| No | 4 | P | Indirect | Held by Chali Properties LLC |
Footnotes
- The shares were acquired in multiple trades at prices ranging from $27.06 to $27.21. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.
- The Reporting Person holds voting and dispositive power over the shares held by Chali Properties LLC.
- The shares were acquired in multiple trades at prices ranging from $27.69 to $28.00. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.
Billionaire Hedge Funds
